TrialLancet (London, England)2015

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.

Benjamin Z Leder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.